These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2708 related items for PubMed ID: 14752420

  • 1. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.
    J Clin Oncol; 2010 Feb 20; 28(6):942-8. PubMed ID: 20100967
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3480-7. PubMed ID: 15908657
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 20; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 5. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.
    Ann Thorac Surg; 2009 Sep 20; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [Abstract] [Full Text] [Related]

  • 6. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocol.
    Hehr T, Friedel G, Steger V, Spengler W, Eschmann SM, Bamberg M, Budach W.
    Int J Radiat Oncol Biol Phys; 2010 Apr 01; 76(5):1376-81. PubMed ID: 19864078
    [Abstract] [Full Text] [Related]

  • 8. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.
    Ann Thorac Surg; 1995 Sep 01; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [Abstract] [Full Text] [Related]

  • 9. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J, Pang QS, Wang P, Wang J, Wang W.
    Zhonghua Zhong Liu Za Zhi; 2007 Oct 01; 29(10):769-72. PubMed ID: 18396691
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 11. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 Nov 20; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 12. Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC).
    De Candis D, Stani SC, Bidoli P, Bedini VA, Potepan P, Navarria P, Aglione S, Bajetta E.
    Am J Clin Oncol; 2003 Jun 20; 26(3):265-9. PubMed ID: 12796598
    [Abstract] [Full Text] [Related]

  • 13. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W, Collaud S, Eberhardt WE, Hillinger S, Welter S, Stahel R, Stamatis G.
    J Thorac Cardiovasc Surg; 2010 Jun 20; 139(6):1424-30. PubMed ID: 20416887
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP, Leonardo JM, Karlsson U, Vos P, Bullock L, Thomas P, Lepera P, Ludin A, Chu C, Salehpour M, Jendrasiak G, Sallah S.
    Anticancer Res; 2002 Jun 20; 22(6B):3429-35. PubMed ID: 12552935
    [Abstract] [Full Text] [Related]

  • 15. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 17. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG, Pappalardo A, Russo A, Santini D, Di Rosa C, Di Salvo C, Castorina S, Marletta F, Bellissima G, Palermo N, Scuderi C, Bordonaro R.
    Anticancer Drugs; 2007 Jul 15; 18(6):713-9. PubMed ID: 17762402
    [Abstract] [Full Text] [Related]

  • 18. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
    Fischer S, Darling G, Pierre AF, Sun A, Leighl N, Waddell TK, Keshavjee S, de Perrot M.
    Eur J Cardiothorac Surg; 2008 Jun 15; 33(6):1129-34. PubMed ID: 18407511
    [Abstract] [Full Text] [Related]

  • 19. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E, Stupp R, Zouhair A, Guillou L, Taffé P, von Briel C, Krueger T, Ris HB.
    Eur J Cardiothorac Surg; 2005 Jun 15; 27(6):1092-8. PubMed ID: 15896624
    [Abstract] [Full Text] [Related]

  • 20. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
    Allen AM, Mentzer SJ, Yeap BY, Soto R, Baldini EH, Rabin MS, Sugarbaker DJ, Bueno R.
    Cancer; 2008 Mar 01; 112(5):1106-13. PubMed ID: 18286507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 136.